Growth inhibiting effects of cytotoxic agents on human tumor and tumor-bearing normal tissue in vitro.
D002288:Adenocarcinoma, Mucinous / Q000378:metabolism; D000368:Aged; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000378:metabolism*; D002277:Carcinoma / Q000378:metabolism; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000378:metabolism; D002291:Carcinoma, Papillary / Q000378:metabolism; D003520:Cyclophosphamide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D009696:Nucleic Acids / Q000096:biosynthesis*; D010759:Phosphorus Isotopes; D013274:Stomach Neoplasms / Q000378:metabolism*; D013852:Thiotepa / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000970:Antineoplastic Agents; D009696:Nucleic Acids; D010759:Phosphorus Isotopes; D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil